<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34163010</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-5438</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>European journal of human genetics : EJHG</Title>
          <ISOAbbreviation>Eur J Hum Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pathogenic variants in PIDD1 lead to an autosomal recessive neurodevelopmental disorder with pachygyria and psychiatric features.</ArticleTitle>
        <Pagination>
          <StartPage>1226</StartPage>
          <EndPage>1234</EndPage>
          <MedlinePgn>1226-1234</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41431-021-00910-0</ELocationID>
        <Abstract>
          <AbstractText>The PIDDosome is a multiprotein complex, composed by the p53-induced death domain protein 1 (PIDD1), the bipartite linker protein CRADD (also known as RAIDD) and the proform of caspase-2 that induces apoptosis in response to DNA damage. In the recent years, biallelic pathogenic variants in CRADD have been associated with a neurodevelopmental disorder (MRT34; MIM 614499) characterized by pachygyria with a predominant anterior gradient, megalencephaly, epilepsy and intellectual disability. More recently, biallelic pathogenic variants in PIDD1 have been described in a few families with apparently nonsydnromic intellectual disability. Here, we aim to delineate the genetic and radio-clinical features of PIDD1-related disorder. Exome sequencing was carried out in six consanguineous families. Thorough clinical and neuroradiological evaluation was performed for all the affected individuals as well as reviewing all the data from previously reported cases. We identified five distinct novel homozygous variants (c.2584C&gt;T p.(Arg862Trp), c.1340G&gt;A p.(Trp447*), c.2116_2120del p.(Val706Hisfs*30), c.1564_1565delCA p.(Gln522fs*44), and c.1804_1805del p.(Gly602fs*26) in eleven subjects displaying intellectual disability, behaviorial and psychiatric features, and a typical anterior-predominant pachygyria, remarkably resembling the CRADD-related neuroimaging pattern. In summary, we outlin`e the phenotypic and molecular spectrum of PIDD1 biallelic variants supporting the evidence that the PIDD1/CRADD/caspase-2 signaling is crucial for normal gyration of the developing human neocortex as well as cognition and behavior.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Zaki</LastName>
            <ForeName>Maha S</ForeName>
            <Initials>MS</Initials>
            <Identifier Source="ORCID">0000-0001-7840-0002</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Accogli</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>The Department of Medical Genetics, McGill University Health Centre, Montreal, QC, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mirzaa</LastName>
            <ForeName>Ghayda</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0003-2648-7657</Identifier>
            <AffiliationInfo>
              <Affiliation>Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rahman</LastName>
            <ForeName>Fatima</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Development and Behavioural Pediatrics Department, Institute of Child Health and The Children Hospital, Lahore, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohammed</LastName>
            <ForeName>Hiba</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>American centre for Psychiatry and Neurology', Abu Dhabi, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Porras-Hurtado</LastName>
            <ForeName>Gloria Liliana</ForeName>
            <Initials>GL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, INCERHC International center research health Comfamiliar - Salud Comfamiliar, Comfamiiar Risaralda, Pereira, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Efthymiou</LastName>
            <ForeName>Stephanie</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-4900-9877</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, WC1N3BG London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maqbool</LastName>
            <ForeName>Shazia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Development and Behavioural Pediatrics Department, Institute of Child Health and The Children Hospital, Lahore, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shukla</LastName>
            <ForeName>Anju</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vincent</LastName>
            <ForeName>John B</ForeName>
            <Initials>JB</Initials>
            <Identifier Source="ORCID">0000-0003-0692-2519</Identifier>
            <AffiliationInfo>
              <Affiliation>Molecular Neuropsychiatry &amp; Development (MiND) Lab, Campbell Family Mental Health, Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hussain</LastName>
            <ForeName>Abrar</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Human Molecular Genetics Lab, Department of Biological Sciences, FBAS, International Islamic University, Islamabad, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mir</LastName>
            <ForeName>Asif</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Human Molecular Genetics Lab, Department of Biological Sciences, FBAS, International Islamic University, Islamabad, Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beetz</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0001-7061-2895</Identifier>
            <AffiliationInfo>
              <Affiliation>CENTOGENE AG, Rostock, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leubauer</LastName>
            <ForeName>Anika</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-8402-5448</Identifier>
            <AffiliationInfo>
              <Affiliation>CENTOGENE AG, Rostock, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Houlden</LastName>
            <ForeName>Henry</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0002-2866-7777</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, WC1N3BG London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gleeson</LastName>
            <ForeName>Joseph G</ForeName>
            <Initials>JG</Initials>
            <Identifier Source="ORCID">0000-0002-6713-8018</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurosciences, University of California, San Diego, CA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Rady Children's Institute for Genomic Medicine, San Diego, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maroofian</LastName>
            <ForeName>Reza</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0001-6763-1542</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, WC1N3BG London, London, UK. r.maroofian@ucl.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>WT093205 MA</GrantID>
            <Acronym>WT_</Acronym>
            <Agency>Wellcome Trust</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MR/S005021/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>FC001187</GrantID>
            <Acronym>ARC_</Acronym>
            <Agency>Arthritis Research UK</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>WT104033AIA</GrantID>
            <Acronym>WT_</Acronym>
            <Agency>Wellcome Trust</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MR/S01165X/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <Acronym>WT_</Acronym>
            <Agency>Wellcome Trust</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>FC001187</GrantID>
            <Acronym>WT_</Acronym>
            <Agency>Wellcome Trust</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>G0601943</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>P50 HD103524</GrantID>
            <Acronym>HD</Acronym>
            <Agency>NICHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>06</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Eur J Hum Genet</MedlineTA>
        <NlmUniqueID>9302235</NlmUniqueID>
        <ISSNLinking>1018-4813</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053418">Death Domain Receptor Signaling Adaptor Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C485896">PIDD1 protein, human</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053418" MajorTopicYN="N">Death Domain Receptor Signaling Adaptor Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002658" MajorTopicYN="N">Developmental Disabilities</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005808" MajorTopicYN="N">Genes, Recessive</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008607" MajorTopicYN="N">Intellectual Disability</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054082" MajorTopicYN="N">Lissencephaly</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34163010</ArticleId>
        <ArticleId IdType="pmc">PMC8385073</ArticleId>
        <ArticleId IdType="doi">10.1038/s41431-021-00910-0</ArticleId>
        <ArticleId IdType="pii">10.1038/s41431-021-00910-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science. 2004;304:843–6. doi: 10.1126/science.1095432.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1095432</ArticleId>
            <ArticleId IdType="pubmed">15073321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janssens S, Tinel A. The PIDDosome, DNA-damage-induced apoptosis and beyond. Cell Death Differ. 2012;19:13–20. doi: 10.1038/cdd.2011.162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2011.162</ArticleId>
            <ArticleId IdType="pmc">PMC3252840</ArticleId>
            <ArticleId IdType="pubmed">22095286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang TH, Park HH. PIDD mediates and stabilizes the interaction between RAIDD and caspase-2 for the PIDDosome assembly. BMB Rep. 2013;46:471–6. doi: 10.5483/BMBRep.2013.46.9.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5483/BMBRep.2013.46.9.021</ArticleId>
            <ArticleId IdType="pmc">PMC4133880</ArticleId>
            <ArticleId IdType="pubmed">24064063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Donato N, Jean YY, Maga AM, Krewson BD, Shupp AB, Avrutsky MI, et al.  Mutations in CRADD result in reduced caspase-2-mediated neuronal apoptosis and cause megalencephaly with a rare lissencephaly variant. Am J Hum Genet. 2016;99:1117–29. doi: 10.1016/j.ajhg.2016.09.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2016.09.010</ArticleId>
            <ArticleId IdType="pmc">PMC5097945</ArticleId>
            <ArticleId IdType="pubmed">27773430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sladky VC, Villunger A. Uncovering the PIDDosome and caspase-2 as regulators of organogenesis and cellular differentiation. Cell Death Differ. 2020;27:2037–47. doi: 10.1038/s41418-020-0556-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41418-020-0556-6</ArticleId>
            <ArticleId IdType="pmc">PMC7308375</ArticleId>
            <ArticleId IdType="pubmed">32415279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sladky V, Schuler F, Fava LL, Villunger AJ. The resurrection of the PIDDosome - emerging roles in the DNA-damage response and centrosome surveillance. Cell Sci. 2017;130:3779–87. doi: 10.1242/jcs.203448.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.203448</ArticleId>
            <ArticleId IdType="pubmed">29142064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fava LL, Schuler F, Sladky V, Haschka MD, Soratroi C, Eiterer L, et al.  The PIDDosome activates p53 in response to supernumerary centrosomes. Genes Dev. 2017;31:34–45. doi: 10.1101/gad.289728.116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.289728.116</ArticleId>
            <ArticleId IdType="pmc">PMC5287111</ArticleId>
            <ArticleId IdType="pubmed">28130345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harripaul R, Vasli N, Mikhailov A, Rafiq MA, Mittal K, Windpassinger C, et al.  Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families. Mol Psychiatry. 2018;23:973–84. doi: 10.1038/mp.2017.60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2017.60</ArticleId>
            <ArticleId IdType="pubmed">28397838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu H, Kahrizi K, Musante L, Fattahi Z, Herwig R, Hosseini M, et al.  Genetics of intellectual disability in consanguineous families. Mol Psychiatry. 2019;24:1027–39. doi: 10.1038/s41380-017-0012-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41380-017-0012-2</ArticleId>
            <ArticleId IdType="pubmed">29302074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sheikh TI, Vasli N, Pastore S, Kharizi K, Harripaul R, Fattahi Z, et al.  Biallelic mutations in the death domain of PIDD1 impair caspase-2 activation and are associated with intellectual disability. Transl Psychiatry. 2021;11:1. doi: 10.1038/s41398-020-01158-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41398-020-01158-w</ArticleId>
            <ArticleId IdType="pmc">PMC7791037</ArticleId>
            <ArticleId IdType="pubmed">33414379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bauer P, Kandaswamy KK, Weiss MER, Paknia O, Werber M, Bertoli-Avella AM, et al.  Development of an evidencebased algorithm that optimizes sensitivity and specificity in ES-based diagnostics of a clinically heterogeneous patient population. Genet Med. 2019;21:53–61. doi: 10.1038/s41436-018-0016-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41436-018-0016-6</ArticleId>
            <ArticleId IdType="pmc">PMC6752300</ArticleId>
            <ArticleId IdType="pubmed">30100613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Periklis M, Reza M, Stray-Pedersen A, Musaev D, Zaki MS, Mahmoud IG, et al.  Biallelic variants in KIF14 cause intellectual disability with microcephaly. Eur J Hum Genet. 2018;26:330–9. doi: 10.1038/s41431-017-0088-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41431-017-0088-9</ArticleId>
            <ArticleId IdType="pmc">PMC5839044</ArticleId>
            <ArticleId IdType="pubmed">29343805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Severino M, Geraldo AF, Utz N, Tortora D, Pogledic I, Klonowski W, et al.  Definitions and classification of malformations of cortical development: practical guidelines. Brain. 2020;143:2874–94. doi: 10.1093/brain/awaa174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awaa174</ArticleId>
            <ArticleId IdType="pmc">PMC7586092</ArticleId>
            <ArticleId IdType="pubmed">32779696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Donato N, Timms AE, Aldinger KA, Mirzaa GM, Bennett JT, Collins S, et al.  Analysis of 17 genes detects mutations in 81% of 811 patients with lissencephaly. Genet Med. 2018;20:1354–64. doi: 10.1038/gim.2018.8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/gim.2018.8</ArticleId>
            <ArticleId IdType="pmc">PMC6195491</ArticleId>
            <ArticleId IdType="pubmed">29671837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valence S, Garel C, Barth M, Toutain A, Paris C, Amsallem D, et al.  RELN and VLDLR mutations underlie two distinguishable clinico-radiological phenotypes. Clin Genet. 2016;90:545–9. doi: 10.1111/cge.12779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cge.12779</ArticleId>
            <ArticleId IdType="pubmed">27000652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ho CSH, Dubeau F, Séguin R, Ducharme S. Prevalence of neuropsychiatric symptoms associated with malformations of cortical development. Epilepsy Behav. 2019;92:306–10. doi: 10.1016/j.yebeh.2019.01.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yebeh.2019.01.011</ArticleId>
            <ArticleId IdType="pubmed">30731297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chatterjee SS, Talapatra D, Acharya R, Sarkhel S. Pachygyria presented as mania. Indian J Psychol Med. 2015;37:452–425. doi: 10.4103/0253-7176.168595.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0253-7176.168595</ArticleId>
            <ArticleId IdType="pmc">PMC4676216</ArticleId>
            <ArticleId IdType="pubmed">26702182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polla DL, Rahikkala E, Bode MK, Määttä T, Varilo T, Loman T, et al.  Phenotypic spectrum associated with a CRADD founder variant underlying frontotemporal predominant pachygyria in the Finnish population. Eur J Hum Genet. 2019;27:1235–43. doi: 10.1038/s41431-019-0383-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41431-019-0383-8</ArticleId>
            <ArticleId IdType="pmc">PMC6777631</ArticleId>
            <ArticleId IdType="pubmed">30914828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muraki K, Tanigaki K. Neuronal migration abnormalities and its possible implications for schizophrenia. Front Neurosci. 2015;9:74. doi: 10.3389/fnins.2015.00074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2015.00074</ArticleId>
            <ArticleId IdType="pmc">PMC4354421</ArticleId>
            <ArticleId IdType="pubmed">25805966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan Y-H, Wu N, Yuan X-B. Toward a better understanding of neuronal migration deficits in autism spectrum disorders. Front Cell Dev Biol. 2019;7:205. doi: 10.3389/fcell.2019.00205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2019.00205</ArticleId>
            <ArticleId IdType="pmc">PMC6763556</ArticleId>
            <ArticleId IdType="pubmed">31620440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukuda T, Yanagi S. Psychiatric behaviors associated with cytoskeletal defects in radial neuronal migration. Cell Mol Life Sci. 2017;74:3533–52. doi: 10.1007/s00018-017-2539-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-017-2539-4</ArticleId>
            <ArticleId IdType="pubmed">28516224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manzl C, Krumschnabel G, Bock F, Sohm B, Labi V, Baumgartner F, et al.  Caspase-2 activation in the absence of PIDDosome formation. J Cell Biol. 2009;185:291–303. doi: 10.1083/jcb.200811105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200811105</ArticleId>
            <ArticleId IdType="pmc">PMC2700374</ArticleId>
            <ArticleId IdType="pubmed">19364921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Favaloro B, Allocati N, Graziano V, Di Ilio C, De Laurenzi V. Role of apoptosis in disease. Aging. 2012;4:330–49. doi: 10.18632/aging.100459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/aging.100459</ArticleId>
            <ArticleId IdType="pmc">PMC3384434</ArticleId>
            <ArticleId IdType="pubmed">22683550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ribe EM, Jean YY, Goldstein RL, Manzl C, Stefanis L, Villunger A, et al.  Neuronal caspase 2 activity and function requires RAIDD, but not PIDD. Biochem J. 2012;444:591–9. doi: 10.1042/BJ20111588.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20111588</ArticleId>
            <ArticleId IdType="pmc">PMC3365438</ArticleId>
            <ArticleId IdType="pubmed">22515271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Narkilahti S, Jutila L, Alafuzoff I, Karkola K, Paljärvi L, Immonen A, et al. Increased expression of caspase 2 in experimental and human temporal lobe epilepsy. Neuromolecular Med. 2007; 9:129–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17627033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pozueta J, Lefort R, Ribe EM, Troy CM, Arancio O, Shelanski M. Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice. Nat Commun. 2013;4:1939. doi: 10.1038/ncomms2927.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms2927</ArticleId>
            <ArticleId IdType="pmc">PMC4398315</ArticleId>
            <ArticleId IdType="pubmed">23748737</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
